Stocktoria
Syndax Pharmaceuticals Inc SNDX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2016-03-03
Syndax Pharmaceuticals Inc insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Botwood Nicholas A.J. | Head of R&D, CMO | 2026-06-12 | Sell | 31,235 | $18.14 |
| Botwood Nicholas A.J. | Head of R&D, CMO | 2026-06-12 | Option exercise | 31,235 | $13.82 |
| Botwood Nicholas A.J. | Head of R&D, CMO | 2026-06-11 | Option exercise | 22,515 | $13.82 |
| Botwood Nicholas A.J. | Head of R&D, CMO | 2026-06-11 | Sell | 34,280 | $18.00 |
| Goldan Keith A. | Chief Financial Officer | 2026-06-01 | Sell | 1,177 | $18.99 |
| Metzger Michael A | Chief Executive Officer | 2026-06-01 | Sell | 6,847 | $18.99 |
| Goldan Keith A. | Chief Financial Officer | 2026-02-09 | Sell | 3,410 | $21.03 |
| Metzger Michael A | Chief Executive Officer | 2026-02-09 | Sell | 17,159 | $21.03 |
Source: SEC EDGAR filings · CIK 0001395937 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.